Showing results (241-250 of 708) with videos related to
Sort By:
Pageof 71
Annali Italiani Di Medicina Interna : Organo Ufficiale Della Societa Italiana Di Medicina Interna|October 1, 1993
[Hypertension, left ventricular hypertrophy and heart failure]G Mancia, C Giannattasio, G GrassiAnnali Italiani Di Medicina Interna : Organo Ufficiale Della Societa Italiana Di Medicina Interna|October 17, 1998
[Sympathetic nervous factors, pressure variability and organ damage in arterial hypertension]G Mancia, G Seravalle, G GrassiJournal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|September 1, 1996
Safety of the calcium antagonist lacidipine evaluated from a phase III-IV trial databaseL H Lindholm, P Tcherdakoff, A ZanchettiBlood Pressure|July 1, 1996
Safety aspects of treatment with lacidipine--a slow-onset, long-acting calcium antagonistL H Lindholm, P Tcherdakoff, A ZanchettiJournal of Human Hypertension|December 1, 1992
Atherosclerosis and calcium antagonists: the VHAS. The Verapamil-Hypertension Atherosclerosis Study (VHAS) InvestigatorsA Zanchetti, B Magnani, C Dal PalùThe Journal of Physiology|March 1, 1976
Haemodynamic responses and renin release during stimulation of afferent renal nerves in the catF R Calaresu, A Stella, A ZanchettiJournal of Hypertension|August 1, 1993
Evaluation of organ damage in hypertensionA Zanchetti, P Sleight, W H BirkenhägerDrugs|January 1, 1992
Preliminary clinical experience with calcium antagonists in atherosclerosis. Verapamil in Hypertension Atherosclerosis Study InvestigatorsB Magnani, C Dal Palù, A ZanchettiJournal of Hypertension|October 30, 1998
Risk factors associated with alterations in carotid intima-media thickness in hypertension: baseline data from the European Lacidipine Study on AtherosclerosisA Zanchetti, M G Bond, M Hennig, et al.Annals of the New York Academy of Sciences|August 15, 1996
Neural cardiovascular regulation and 24-hour blood pressure and heart rate variabilityG Parati, M Di Rienzo, G ManciaPageof 71